Fig. 6: Activity of chimeric endolysin CHAPk and CHAPk-SH3bk in in-vivo mice skin-infection model.

a Graph representing biofilm reduction activity of CHAPk and CHAPk-SH3bk against 24-hour S. aureus (ATCC® BAA-44™) biofilm formed on mice skin. b Representative images showing the appearance of mice skin after the treatment of 24 h MRSA biofilm in in-vivo skin infection model.